Trial Profile
Phase I/II study of first line chemotherapy with TS-1 in elderly patients with advanced non-small cell lung cancer.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 13 Jan 2010
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 13 Jan 2010 New trial record